<- Go Home

Imricor Medical Systems, Inc.

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company’s products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device’s conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Market Cap

AUD 392.7M

Volume

294.4K

Cash and Equivalents

AUD 60.5M

EBITDA

-AUD 26.7M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-AUD 2.8M

Profit Margin

2322.43%

52 Week High

AUD 1.57

52 Week Low

AUD 0.89

Dividend

N/A

Price / Book Value

13.32

Price / Earnings

-8.94

Price / Tangible Book Value

13.32

Enterprise Value

AUD 359.2M

Enterprise Value / EBITDA

-13.70

Operating Income

-AUD 27.4M

Return on Equity

143.12%

Return on Assets

-26.53

Cash and Short Term Investments

AUD 67.5M

Debt

AUD 34.0M

Equity

AUD 29.1M

Revenue

AUD 120.1K

Unlevered FCF

-AUD 10.4M

Sector

Health Care Equipment and Supplies

Category

N/A

Company Stock Pitches